1. Academic Validation
  2. HBx-Derived Constrained Peptides Inhibit the Secretion of Hepatitis B Virus Antigens

HBx-Derived Constrained Peptides Inhibit the Secretion of Hepatitis B Virus Antigens

  • Mol Pharm. 2018 Dec 3;15(12):5646-5652. doi: 10.1021/acs.molpharmaceut.8b00807.
Xiaodan Cai 1 Weihao Zheng 1 2 Xiaodong Shi 1 Longjian Chen 1 Zhihong Liu 1 Zigang Li 1
Affiliations

Affiliations

  • 1 State Key Laboratory of Chemical Oncogenomics, School of Chemical Biology and Biotechnology , Peking University Shenzhen Graduate School , Shenzhen 518055 , China.
  • 2 Division of Experimental Medicine, Department of Medicine , University of California, San Francisco , San Francisco , California 94110 , United States.
Abstract

Hepatitis B virus (HBV) Infection is the primary cause of cirrhosis and liver Cancer. Protein-protein interactions (PPIs) between HBV x protein (HBx) and its host targets, including Bcl-2, are important for cell death and viral replication. No modulators targeting these PPIs have been reported yet. Here, we developed HBx-derived constrained Peptides generated by a facile macrocyclization method by joining two methionine side chains of unprotected Peptides with chemoselective alkylating linkers. The resulting constrained Peptides with improved cell permeability and binding affinity were effective anti-HBV modulators by blocking the secretion of viral antigens. This study clearly demonstrated HBx as a potentially important PPI target and the potential application of this efficient peptide macrocyclization strategy for targeting key PPIs.

Keywords

Bcl-2; HBeAg; HBsAg; HBx; hepatitis B virus; inhibitor; peptide; protein−protein interaction.

Figures
Products